Sean Duffy Sells 25,886 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) CEO Sean Duffy sold 25,886 shares of the business’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $22.68, for a total transaction of $587,094.48. Following the completion of the transaction, the chief executive officer owned 411,861 shares of the company’s stock, valued at approximately $9,341,007.48. This trade represents a 5.91% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Omada Health Trading Up 0.7%

NASDAQ:OMDA opened at $23.00 on Wednesday. Omada Health, Inc. has a 12-month low of $10.28 and a 12-month high of $26.92. The firm has a market cap of $1.37 billion and a PE ratio of -85.19. The stock has a fifty day moving average price of $17.66 and a 200 day moving average price of $15.21.

Omada Health (NASDAQ:OMDA) last posted its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The company had revenue of $78.05 million for the quarter. Equities analysts forecast that Omada Health, Inc. will post -0.01 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on OMDA. Citigroup restated an “outperform” rating on shares of Omada Health in a report on Friday, May 8th. Weiss Ratings upgraded shares of Omada Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, June 26th. Barclays raised their price target on Omada Health from $18.00 to $20.00 and gave the company an “overweight” rating in a research note on Friday, May 8th. Morgan Stanley reaffirmed an “overweight” rating and set a $30.00 price target on shares of Omada Health in a report on Monday, June 22nd. Finally, Citizens Jmp increased their price objective on Omada Health from $18.00 to $21.00 and gave the company a “market outperform” rating in a report on Friday, May 8th. Ten investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $22.91.

Institutional Investors Weigh In On Omada Health

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Quarry LP acquired a new position in Omada Health in the fourth quarter valued at $29,000. TD Waterhouse Canada Inc. purchased a new position in shares of Omada Health during the fourth quarter worth about $32,000. Raymond James Financial Inc. acquired a new stake in shares of Omada Health during the second quarter worth about $32,000. Inlight Wealth Management LLC purchased a new stake in shares of Omada Health in the 4th quarter valued at about $45,000. Finally, Versant Capital Management Inc boosted its position in shares of Omada Health by 319.3% in the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after purchasing an additional 2,283 shares during the period.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.